Detalles de la búsqueda
1.
Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression.
Immunity
; 41(5): 815-29, 2014 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25453823
2.
Pharmacokinetics of Prenylflavonoids following Oral Ingestion of Standardized Epimedium Extract in Humans.
Planta Med
; 85(4): 347-355, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30522143
3.
Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations.
Br J Clin Pharmacol
; 79(2): 241-53, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25125025
4.
A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies.
Support Care Cancer
; 23(8): 2231-44, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25564221
5.
Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence.
Breast Cancer Res Treat
; 133(2): 703-11, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22370628
6.
Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats.
J Cardiovasc Pharmacol
; 57(4): 469-78, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21283019
7.
BSA and ABCB1 polymorphism affect the pharmacokinetics of sunitinib and its active metabolite in Asian mRCC patients receiving an attenuated sunitinib dosing regimen.
Cancer Chemother Pharmacol
; 78(3): 623-32, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27485537
8.
Formation of reactive metabolites and management of tyrosine kinase inhibitor-induced hepatotoxicity: a literature review.
Expert Opin Drug Metab Toxicol
; 11(2): 231-42, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25400226
9.
Association of drug exposure with toxicity and clinical response in metastatic renal cell carcinoma patients receiving an attenuated dosing regimen of sunitinib.
Target Oncol
; 10(3): 429-37, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25502986
10.
Role of sunitinib and SU12662 on dermatological toxicities in metastatic renal cell carcinoma patients: in vitro, in vivo, and outcomes investigation.
Cancer Chemother Pharmacol
; 73(2): 381-8, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24306119
11.
Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: a meta-analysis.
Cancer Treat Rev
; 39(2): 199-206, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23099278
Resultados
1 -
11
de 11
1
Próxima >
>>